Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET Â | Source: Rocket Doctor AI Inc. Vancouver,…
Eisai Submits New Drug Application for Subcutaneous Formulation of LEQEMBI for the Treatment of Early Alzheimers Disease in Japan
If approved, lecanemab would be the first and only anti-amyloid treatment in…